Adjuvant Chemotherapy Alone for Endometrial Ca – GOG-258 and Beyond
Lecture Presentation: 2018 Biennial Meeting
Gini Fleming | USA

How to Achieve a 100% Cure Rate in Low Risk GTN
Lecture Presentation: 2018 Biennial Meeting
Nienke van Trommel | The Netherlands

Uterine Serous Carcinoma
Lecture Presentation: 2018 Biennial Meeting
Jonathan Ledermann | United Kingdom

Radiotherapy and/or Chemotherapy for Stage III Endometrial Cancer – PORTEC-3 & Beyond
Lecture Presentation: 2018 Biennial Meeting
Carien Creuztberg | The Netherlands

Vaginal Brachytherapy Versus External Beam Pelvic Radiotherapy For High-Intermediate Risk Endometrial Cancer: Long Term Results Of The Randomized Portec-2 Trial
Education Exchange from the 2016 Meeting IGCS Biennial Meeting
Remi Nout | Netherlands

The Era Of Translational Therapies For Endometrial Cancer
Lecture Presentation: 2016 Biennial Meeting
Nicoletta Colombo| Italy

Adjuvant Treatment Without Surgical Staging Information
Lecture Presentation: 2016 Biennial Meeting
Carien Creutzberg | Netherlands

The Memorial Sloan Kettering View Point – Pro/Con Sentinel Lymph Node: A Discussion Of The Role Of SLN Mapping In Endometrial Cancer
Lecture Presentation: 2016 Biennial Meeting
Nadeem Abu-Rustum | USA

Adjuvant Treatment Without Surgical Staging Information
Lecture Presentation: 2014 Biennial Meeting
Janda Monika  | Australia

Antiangiogenics and New Targets
Lecture Presentation: 2018 Biennial Meeting
Stephanie Lheureux | Canada

Immunotherapy, Single Agent and Combination
Lecture Presentation: 2018 Biennial Meeting
Kathleen Moore | USA

Endocrine Therapy, Updates and Combinations
Lecture Presentation: 2018 Biennial Meeting
Gini Fleming | USA

When to Use Pelvic Radiotherapy for Stage I-II Endometrial Cancer – GOG 249 and Beyond 
Lecture Presentation: 2018 Biennial Meeting
Anuja Jhingran | USA

When to Use Vaginal Brachytherapy Alone for Endometrial Cancer
Lecture Presentation: 2018 Biennial Meeting
Remi Nout | The Netherlands

Radiotherapy and/or Chemotherapy for Stage III Endometrial Cancer – PORTEC-3 & Beyond
Lecture Presentation: 2018 Biennial Meeting
Carien Creuztberg | The Netherlands

Controversies in SLN in Endometrial Cancer – They Mayo Clinic and MSKCC Perspectives 
Lecture Presentation: 2018 Biennial Meeting
Andrea Mariani | USA

Controversies in Surgical Staging of Endometrial Cancer
Lecture Presentation: 2018 Biennial Meeting
Alison Brand | Australia

Role of SLN in High Grade Histology 
Lecture Presentation: 2018 Biennial Meeting
Pam Soliman | USA

Added Value of SLN in Endometrial Cancer 
Lecture Presentation: 2018 Biennial Meeting
Walter Gotlieb | Canada

Vaginal Brachytherapy Versus External Beam Pelvic Radiotherapy For High-Intermediate Risk Endometrial Cancer: Long Term Results Of The Randomized Portec-2 Trial
Education Exchange from the 2016 IGCS Biennial Meeting
Remi Nout | Netherlands

Disease-Free And Overall-Survival After Total Laparoscopy Versus Open Abdominal Hysterectomy For Early Stage Endometrial Cancer: Results From The LACE Trial
Lecture Presentation: 2016 Biennial Meeting
Education Exchange from the 2016 IGCS Biennial Meeting
Andreas Obermair | Australia

Sentinel Lymph Node Mapping Accurately Identifies Positive Nodes In Women With High Risk Endometrial Cancer: A Prospective Validation Trial
Education Exchange from the 2016 Meeting IGCS Biennial Meeting
Pamela Soliman | USA

Sentinel Lymph Node Mapping In Uterine Cancer
Lecture Presentation: 2016 Biennial Meeting
Nadeem Abu-Rustum | USA